Volpara Health Technologies Ltd Posts “strong” Trading Update

ASX-listed health technology company Volpara Health Technologies Ltd (ASX:VHT) this morning provided a trading update to investors.

ASX-listed health technology company Volpara Health Technologies Ltd (ASX: VHT) this morning provided a trading update to investors.

In an announcement to the ASX, the small-cap company said its annual recurring revenue (ARR) is now $NZ2.6 million, up strongly on the prior year. Total Contract Value (TCV) signed during the third quarter stood at $NZ2.4 million, up 5%, at 15 December.

“These figures demonstrate that this has been a great quarter, and we still have two strong
weeks of US sales activity ahead,” CEO Dr Ralph Highnam said.

“This quarter we have grown sales and seen increased deal flow, while keeping costs flat compared to last year, proving that we have a scalable, sticky product that is being well received in the US market, where we have first-mover advantages.”

Volpara is a New Zealand-based health technology company which was founded in 2009. The company develops digital solutions for breast cancer screening, helping to identify women who have a high risk of developing breast cancer.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

5%+ in passive income

Owen Rask’s investing report available

With bond ETFs like ASX:IAF and the S&P 500 riding high, now could be one of the best times to start earning passive income from a portfolio of shares and ETFs.

In this free analyst report, our Chief Investment Officer, Owen Rask, names 10 ASX stocks and ETFs to watch.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Skip to content